DNA Gyrase Subunit B (EC 5.99.1.3) Market to Witness Growth Acceleration by 2029
DNA gyrase subunit B (EC 5.99.1.3) market is anticipated to grow at a significant CAGR during the forecast period. DNA gyrase is an essential bacterial enzyme that belongs to the topoisomerases class of enzymes that controls the topological transitions of DNA. Additionally, it catalyzes the ATP-dependent negative super-coiling of double-stranded closed-circular DNA. The major factor accelerating the growth of the market is the increasing prevalence of bacterial infections across the globe.
Moreover, based on application,
the market is segmented into bacterial infections, clostridium diffclie
infections, klebsiella pneumoniae infections, and others. Clostridium diffclie
infections are anticipated to hold a major share in the market due to the
rising incidence rate. According to the National Center for Biotechnology
Information (NCBI), in 2017, there was an estimated 235,700 cases with an
estimated incidence rate of 73.3 per 100,000 population in the US.
Some major players in the market
include Bristol-Myers Squibb Co., AstraZeneca Plc, and Merck & Co., Inc.,
among others. The market players are contributing significantly to the growth
of the market by the adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in October 2019,
GlaxoSmithKline Plc announced the beginning of patient dosing in a phase III
clinical programme investigating gepotidacin. Gepotidacin is a new chemical
class of antibiotics called triazaacenaphthylene bacterial topoisomerase
inhibitors used for the treatment of patients with uncomplicated urinary tract
infection and urogenital gonorrhoea (GC). The drug works by interacting with
two key bacterial enzymes, DNA gyrase and topoisomerase IV
To Request a Sample of our Report on DNA Gyrase Subunit
B (EC 5.99.1.3) Market:
https://www.omrglobal.com/request-sample/dna-gyrase-subunit-b-ec-59913-market
Market Coverage
• The market number available for – 2021-2029
• Base year- 2021
• Forecast period- 2023-2029
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
Bristol-Myers Squibb Co., AstraZeneca Plc, and Merck & Co., Inc., among
others.
DNA Gyrase Subunit B (EC 5.99.1.3) Market Report by
Segment
By Type
• GYR-12
• DS-2969
• VXC-100
• VT-12008911
• Others
By Application
• Bacterial Infections
• Clostridium Diffclie Infections
• Klebsiella Pneumoniae Infections
• Others
A
full Report of DNA Gyrase Subunit B (EC 5.99.1.3) Market is Available @ https://www.omrglobal.com/industry-reports/dna-gyrase-subunit-b-ec-59913-market
DNA Gyrase Subunit B (EC 5.99.1.3) Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment